Exploring the Role of MIA-602 in Overcoming Doxorubicin-resistance in Acute Myeloid Leukemia
April 11, 2024
PRESS RELEASE: On April 8, 2024, a new research paper was published in Oncotarget, entitled, “Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.” continue reading »